TRML NASDAQ
Tourmaline Bio, Inc.
1W: +0.0%
1M: +0.2%
3M: +120.5%
1Y: +74.8%
3Y: +574.8%
$47.98
Last traded 2025-10-30 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-98.2% YoY
$-88M
Net Income
-74.5% YoY
$-86M
Free Cash Flow
-79.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-29.6%
ROA-28.8%
ROIC-402.6%
Valuation
P/E-26.8
P/B4.8
EV/EBITDA-1.8
Leverage
Debt/Equity0.00
Current Ratio24.68
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z23.44
Beneish M0.00